IP6 (Inositol Hexaphosphate)
Phytic acid — the six-phosphate ester of inositol that seeds use to store phosphorus. Nutrition textbooks call the identical molecule an antinutrient because it chelates iron and zinc in the gut; the supplement aisle sells it as an antioxidant on the grounds that chelating iron is exactly what stops iron catalyzing free-radical chemistry. Both descriptions are correct, and they are the same property.
IP6 (Inositol Hexaphosphate) quick facts
| Suggested dose | Products carry 500–800 mg of IP6 with inositol, taken once daily and always away from food. Taking it with a meal is the version that predictably removes iron and zinc from that meal. |
| How often | Daily if it is taken at all, and always between meals |
| Who it's for | Almost nobody as a general supplement. The interesting uses are narrow and belong with a clinician who is measuring something. |
This one is easy to take badly. On an empty stomach it has no dietary iron or zinc to bind; taken with meals, long-term, it is a mechanism for iron and zinc depletion working exactly as designed, in the people who can least afford it. Anyone with low ferritin, heavy periods or a plant-based diet should not run it without iron studies. The interesting uses — calcification, crystallization, bone — are narrow, belong with a clinician who is measuring something, and in their best-evidenced form use a different route of administration entirely.
How IP6 (Inositol Hexaphosphate) actually works
Inositol hexakisphosphate is myo-inositol with a phosphate group on all six carbons, giving twelve ionizable protons and, at gut pH, a dense negative charge that binds polyvalent cations avidly — Fe(3+), Zn(2+), Ca(2+). That chelation is one mechanism with two names: in a nutrition textbook it is the antinutrient effect that lowers iron and zinc absorption from cereals and legumes, and on a supplement label it is the antioxidant claim, on the grounds that iron bound to phytate cannot catalyze the Fenton reaction that turns hydrogen peroxide into hydroxyl radical. Both are the same property described by people with different aims. The claimed intracellular effects require the intact hexaphosphate to be absorbed, and the intestinal phosphatases that meet it are efficient at stripping phosphates, so what is absorbed is largely lower inositol phosphates and free inositol. The strongest evidence that oral dosing does not achieve plasma IP6 is commercial: the pharmaceutical version of this molecule, SNF472, is given intravenously.
Where to get IP6 (Inositol Hexaphosphate)
Find IP6 (Inositol Hexaphosphate) on iHerb →The evidence for IP6 (Inositol Hexaphosphate)
Graded by what exists behind each claim.
✅ Clinically validated
- A critical evaluation of the phytate clinical trial literature finds the human evidence is small, heterogeneous and mostly not what the marketing claims; the best-supported effects concern mineral binding and crystallization rather than cancer.
- The one phase 3 randomized, double-blind, placebo-controlled trial of an inositol hexaphosphate drug — SNF472, in calciphylaxis — administers it INTRAVENOUSLY three times a week during dialysis, which is a direct statement about what oral dosing achieves in plasma.
- Work on inositol hexaphosphate in bone reports effects on hydroxyapatite crystal growth, which is the same physical chemistry that underlies both the calcification and the kidney-stone claims.
📊 Correlative data
- Populations eating high-phytate cereal and legume diets have lower rates of some cancers and higher rates of iron and zinc deficiency at the same time, which is the observational base the supplement claim was built on and also the reason it is hard to interpret.
🧪 Theoretical / extrapolated benefits
- The proposed anti-neoplastic mechanism runs through dephosphorylation to lower inositol phosphates that act as intracellular second messengers. The step nobody has demonstrated in humans is that an oral dose ever reaches a tumor cell as IP6 rather than as inositol plus phosphate.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What IP6 (Inositol Hexaphosphate) actually does
One molecule, two names, and the argument between them is the page. Inositol hexakisphosphate is myo-inositol with a phosphate esterified to all six carbons. Twelve ionizable protons give it a dense negative charge across the pH range of the gut, and that charge binds polyvalent cations with high affinity — ferric iron above all, then zinc, then calcium and magnesium.
A nutrition textbook calls that chelation the antinutrient effect. Phytate is the principal reason iron and zinc absorption from cereals and legumes is poor, and the reason soaking, sprouting and fermentation — all of which activate plant phytases — improve mineral status from the same food Petroski 2020.
A supplement label calls the identical chelation the antioxidant effect, and it is not wrong: free ferric and ferrous iron catalyzes the Fenton and Haber-Weiss reactions that convert hydrogen peroxide into hydroxyl radical, and iron sequestered by phytate cannot do that chemistry. Both descriptions are the same property viewed by people with different aims, and any honest page has to say so in one sentence.
The second mechanism is physical rather than metabolic, and it is the better-evidenced one. IP6 adsorbs onto the growing faces of hydroxyapatite and calcium oxalate crystals and stops them extending. That is the basis of the work on inositol hexaphosphate in bone Yoshiko 2024, of the dental applications where it is used against calculus and erosion Druzijanic 2023, and of the one genuine drug in this family.
The claimed intracellular effects require intact IP6 to be absorbed, and that is where the account thins. Intestinal and brush-border phosphatases strip phosphates efficiently, so what crosses is largely lower inositol phosphates and free inositol. The proposed anti-neoplastic mechanism runs through those lower phosphates acting as intracellular second messengers, and no human study has shown an oral dose raising plasma IP6 to a concentration that does anything to a cell.
Cell, rodent, human — and where it stops
The most informative fact about oral IP6 comes from a pharmaceutical company's route of administration.
In people, at phase 3. SNF472 is a formulation of myo-inositol hexaphosphate developed for calciphylaxis and vascular calcification, and the CALCIPHYX study is a randomized, double-blind, placebo-controlled phase 3 trial of it Sinha 2022. It is given INTRAVENOUSLY, three times a week, during hemodialysis Yang 2024. A company that could have made a capsule made an infusion, and that decision is a stronger statement about oral bioavailability than any review sentence.
In the oral clinical literature, the honest summary is that it is thin. A critical evaluation of phytate clinical trials finds the human studies small, heterogeneous and mostly not testing what the supplement is sold for; the better-supported effects concern mineral binding and crystallization rather than the oncology claims that built the category Pires 2023.
The specific obstacle to transfer is therefore not species or dose. It is route. Every mechanism that requires IP6 to be present in plasma or inside a cell has been demonstrated where IP6 was placed there directly. Every mechanism that survives an oral dose is a luminal one — mineral chelation in the gut, and whatever crystallization effects survive in urine.
And the luminal mechanism is the one with a downside. The antinutrient literature is not a rival hypothesis; it is the same effect measured in the population that eats the most of it Petroski 2020.
IP6 (Inositol Hexaphosphate) — which form, and does it matter
Almost every product on the shelf is IP6 plus free myo-inositol, commonly in a 4:1 or 2:1 ratio, on the argument that the two act together. The inositol in the bottle is a well-tolerated molecule with its own literature; it is not the reason the product is being bought, and it makes the label total misleading — an 800 mg serving may be 500 mg IP6.
The salt form determines what else is being swallowed. Phytate is sold as the sodium, calcium or magnesium salt, or as free phytic acid; the calcium salt is self-defeating for anyone taking it to chelate, because it arrives with its own cation already bound.
Timing is the formulation decision that matters most and it is the reverse of most supplements. Taken with a meal, IP6 does its defining job on the iron and zinc in that meal. Taken between meals, there is nothing to bind, which is the only sensible way to take it and is what every product instructs. That single instruction is doing more safety work than any warning on the label.
Exposure arithmetic, and why the numbers do not reach the claims. A typical 500 mg oral dose is small against the 1 to 2 g of phytate a high-legume day already delivers, and it meets the same phosphatases. Against that, the intravenous drug is dosed against body weight and delivered directly into blood during dialysis Yang 2024. The two are separated by orders of magnitude of systemic exposure, not by a formulation tweak.
What would have to be true, and how you would know it was not
The mineral prediction is the one that will actually come true. Somebody taking IP6 with meals for three to six months should see ferritin fall, and in a menstruating adult or a plant-based eater it should fall meaningfully. Serum zinc should follow. That is not a side effect to be watched for — it is the primary predicted consequence of the mechanism working as described Petroski 2020.
The prediction that would support the antioxidant claim, and has not been tested. If sequestering catalytic iron lowers oxidative damage, then a marker of lipid peroxidation should fall while ferritin does. Somebody running both at once would learn whether the tradeoff is worth anything, and nobody has.
The prediction that cuts hardest against the product. If the oncology claim required intact circulating IP6, then oral dosing should produce no measurable plasma IP6 above the level a high-fiber meal produces. That is the experiment the intravenous development route already implies the answer to Sinha 2022, and anybody selling the oral capsule on the strength of the intravenous drug's indication is trading on a route difference.
For the crystallization uses, urinary calcium and 24-hour urine chemistry are the numbers, and they belong to a urologist rather than to a supplement plan.
What nobody has tested yet
Nobody has measured plasma inositol phosphate species after a standard oral supplement dose in a properly powered human study. Everything downstream of that measurement — every intracellular mechanism the category advertises — is unresolvable until somebody does. It is a single pharmacokinetic study and it would settle most of this page.
The bone question runs in two directions at once and has not been resolved. IP6 inhibits hydroxyapatite crystal growth, which is useful in pathological calcification and potentially harmful in mineralizing bone Yoshiko 2024; it also chelates the calcium that bone needs. Which effect dominates in a person taking it for years has never been measured.
And the dental work is promising and small. Applications against calculus and erosion are described Druzijanic 2023, but those are topical uses of a molecule this page is about swallowing, and nobody has tested whether an oral dose reaches saliva at a concentration that does anything.
IP6 (Inositol Hexaphosphate) — its own safety story, not its category's
This product's risk is depletion, not toxicity, and that makes it unusual on this shelf. Nothing here poisons anybody. What it does is remove minerals from food, reliably, by design.
Iron is the first casualty. Phytate is the best-characterized inhibitor of non-heme iron absorption in human nutrition Petroski 2020. Taken with meals over months this is a mechanism for iron-deficiency anemia, and the people most drawn to an antioxidant supplement — plant-based eaters, women with heavy periods, endurance athletes — are exactly the people whose iron margin is smallest. Ferritin before starting, and again at three months, is the minimum.
Zinc is the second, with the same mechanism and no convenient marker: serum zinc is a poor reflection of status, so the honest position is that zinc depletion here is predicted rather than monitorable.
Calcium binding matters for anyone managing bone density, and sits awkwardly beside the bone claims made for the same molecule Yoshiko 2024.
Advanced kidney disease is a specific exclusion. Phosphate handling is the problem those patients already have, this molecule is six phosphates, and the one place it is used in renal medicine it is given intravenously under supervision during dialysis Yang 2024. That is not a precedent for a capsule.
Gastrointestinal upset and loose stool are common at label doses, and the clinical trial literature is too small to characterize long-term oral use at all Pires 2023.
Sources read for this page
- Pires SMG. Phytates as a natural source for health promotion: A critical evaluation of clinical trials. Front Chem 2023 · PMID 37123871
- Petroski W. Is There Such a Thing as “Anti-Nutrients”? A Narrative Review of Perceived Problematic Plant Compounds. Nutrients 2020 · PMID 32987890
- Yang C. SNF472: a novel therapeutic agent for vascular calcification and calciphylaxis. J Nephrol 2024 · PMID 38512376
- Sinha S. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J 2022 · PMID 35035944
- Yoshiko Y. Inositol Hexaphosphate in Bone Health and Disease. Biomolecules 2024 · PMID 39334839
- Druzijanic A. Application of Inositol Hexaphosphate and Inositol in Dental Medicine: An Overview. Biomolecules 2023 · PMID 37371493
How you would know if it worked
These are the markers this product's own mechanism names, which makes them the ones that would show it working.
- Ferritin Retest: 8–12 weeks after starting iron; every 6 months if donating blood.
- Zinc, Plasma Retest: 12 weeks after supplementation.
The cheapest panel carrying Ferritin and at least one other of these is Frequent Illness & Immune Resilience, at $108 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
IP6 (Inositol Hexaphosphate) — safety & side effects
- The defining risk is mineral depletion, not toxicity. Phytate binds non-heme iron and zinc in the gut lumen and removes them from the meal. Taken with food, long term, this is a mechanism for iron-deficiency anemia and low zinc status.
- Anyone with low ferritin, heavy menstrual bleeding, a plant-based diet or a history of iron deficiency should not take this without iron studies, because the mechanism works exactly as intended in the people who can least afford it.
- Calcium binding is the same story one mineral over, and matters for anyone managing bone density.
- GI upset and loose stool are common at the doses on the label.
- Not for people on dialysis or with advanced kidney disease outside medical supervision — phosphate handling is the problem those patients already have, and this molecule is six phosphates.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — IP6 (Inositol Hexaphosphate) in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside IP6 (Inositol Hexaphosphate)
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammation these are aimed at |
| ApoB (Apolipoprotein B) | Cardiovascular risk, measured properly |
| HbA1c (Hemoglobin A1c) | Glycation over three months |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 103 markers A–Z
IP6 (Inositol Hexaphosphate) — frequently asked questions
What is IP6 (Inositol Hexaphosphate)?
Phytic acid — the six-phosphate ester of inositol that seeds use to store phosphorus. Nutrition textbooks call the identical molecule an antinutrient because it chelates iron and zinc in the gut; the supplement aisle sells it as an antioxidant on the grounds that chelating iron is exactly what stops iron catalyzing free-radical chemistry. Both descriptions are correct, and they are the same property.
What is the suggested dose of IP6 (Inositol Hexaphosphate)?
Products carry 500–800 mg of IP6 with inositol, taken once daily and always away from food. Taking it with a meal is the version that predictably removes iron and zinc from that meal. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find IP6 (Inositol Hexaphosphate) dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy IP6 (Inositol Hexaphosphate)?
Coach Cam sources IP6 (Inositol Hexaphosphate) from vetted, top-rated brands on iHerb — use the buy link on this page.
What IP6 (Inositol Hexaphosphate) is used for
IP6 (Inositol Hexaphosphate) appears under 1 goal in the goal router.
Related Longevity & Antioxidants supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.